0 NASDAQ Companies - February 27, 2019Gevo and HCS Group Enter Into Game-Changing, Long-Term Supply Agreement for Renewable Isooctane Worth Up to $180 MillionRead More
0 NASDAQ Companies - February 27, 2019Eidos Therapeutics Initiates ATTRibute-CM, a Phase 3 Study of AG10 in ATTR-CM with Registrational 12-month EndpointRead More
0 NASDAQ Companies - February 27, 2019Idera Pharmaceuticals Completes Enrollment Into the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor TreatmentRead More
0 NASDAQ Companies - February 27, 2019ProQR Reports Fourth Quarter and Full Year 2018 Operating and Financial ResultsRead More
0 NASDAQ Companies - February 27, 2019Antares Pharma to Present at the Raymond James & Associates 40th Annual Institutional Investors ConferenceRead More
0 NASDAQ Companies - February 27, 2019G1 Therapeutics to Host Investor Day 2019 on March 6, 2019Read More
0 NASDAQ Companies - February 27, 2019KVH Industries to Host Fourth Quarter/Year-end Conference Call on March 1, 2019Read More
0 TSX Venture News - February 27, 2019GFG Begins Drilling and Outlines 2019 Exploration Program at its Pen Gold Project West of Timmins, OntarioRead More
0 NASDAQ Companies - February 27, 2019Steve Madden Announces Fourth Quarter and Full Year 2018 Results and Provides Initial Fiscal Year 2019 Sales and EPS GuidanceRead More
